Multiple cell and stimulus specific apoptosis pathways have been identified (1) revealing a complexity of molecular events involved. Tumor necrosis factor (TNFa) is known to activate mitochondria dependent or independent pathways for cell death. These pathways converge to activate effector caspases, caspases 3, 6 and 7 (2). The intermediate events including the substrates and effectors however are not clearly understood. In this report, we have employed ribozyme technology to elucidate some of these intermediate events. We show here that Bid, a pro-apoptotic facilitator that plays an important role in the mitochondrial pathway, can be targeted by Bid-specific ribozymes. MCF7 breast carcinoma cells stably transfected with expression plasmids encoding active (but not inactive or mock) Bid ribozymes showed delayed response to TNFa. This was accompanied by decreased activation of caspases 7 and 9, but not of caspase 8. The data assign caspase 9 as an upstream activator of caspase 7 in TNFa-induced Bid-mediated apoptosis.
INTRODUCTION
Apoptosis plays an important role in development and homeostasis. In general, the complex phenotypes of caspase knockout mice have suggested that multiple mechanisms of caspase activation operate in parallel and that the death signal transduction pathways are both cell-type and stimulus specific (1, 3) .
Caspases are expressed as inactive pro-enzymes and are activated by proteolytic processing at internal aspartate residues upon exposure of cells to the apoptosis-inducing signal. To date, 14 mammalian caspase family members have been identified. Some, including caspases 8, 9 and 10, contain large prodomains and are initiators of cell death. Others, such as caspases 3, 6 and 7, carry small prodomains and mostly are involved in execution of cell death. When caspases are activated, they cleave a number of key substrates resulting in their activation or inactivation which orchestrate the morphological and biochemical features of apoptosis (2, 4) . Treatment with TNFa induces two major cell death cascades such as a mitochondrial independent pathway and a mitochondrial pathway.
In the first one, caspase 3 is directly processed by caspase 8 (2) . Mitochondrial damage is observed in the second pathway, and Bcl-2 family proteins play important roles in this pathway (4) .
Bid is a member of the Bcl-2 family of proteins and acts as a pro-apoptotic facilitator. In proliferating cells, an inactive Bid (p22) localizes into the cytoplasm. However, upon cell death signaling by TNFa or Fas, Bid undergoes posttranslational N-myristoylation and cleavage by activated caspase 8 (5, 6) . The resulting Cterminal Bid (pl5) is translocated to the mitochondria, and binds to Bax or Bak. This complex effects the release of cytochrome c from the mitochondria (7). Caspase 9 is activated by cytochrome c and Apaf-1 and in turn processes effector caspases. Therefore, these two initiator caspases (caspase 8 and 9) activate the same targets (2,4) leading to a series of events that remain poorly defined (Fig 1) .
In this report, we targeted Bid by constructing Bid specific ribozymes. These constructs, active form (AbidRz), inactive form (IbidRz), and tRNA val (Mock), were stably transfected into MCF7 breast carcinoma cells to identify the processing specificity of the effectors.
By analyzing the TNFa induced timedependent activation of caspases in control and Bid targeted cells, we demonstrate that activation of caspases 7 and 9 is mostly Bid dependent and caspase 9 is likely to be an upstream activator/effector of caspase 7.
RESULTS AND DISCUSSION Targeting of Bid by ribozymes in MCF 7 cells
To identify interactions among the effector caspases in a mitochondrial pathway, we used the MCF7 breast carcinoma cell line. These cells have lost caspase 3 owing to a 47-base pair deletion within exon 3 of the caspase 3 gene. This deletion results in the skipping of exon 3 during pre-mRNA splicing, thereby abrogating translation of caspase 3 mRNA and that abolishes the mitochondrial independent apoptotic pathway. However, MCF7 cells are still sensitive to TNFainduced apoptosis (8) , presumably by the mitochondrial pathway. We tried to reduce the amount of Bid protein (a mediator of mitochondrial pathway) by expressing hammerhead ribozymes that can cleave any RNAs at the NUX triplet (9,10). We made three constructs, such as a Bid mRNA targeting active ribozyme (ABidRz), an inactive form (IBidRz; with a single G-to-A mutation at the catalytically important conserved nucleotide), and also tRNA val (an empty control vector). MCF7 cells were transfected with these plasmids and selected in a G418 supplemented growth medium.
Total RNA (2 (Lig) was reverse transcribed and amplified by PCR using ribozyme specific primers and Bid specific primers. The amplified DNA was separated on a 2 % agarose gel. The different clones showed approximately the same level of expression of ribozymes. However, Bid was expressed in cells that contained IBidRz and Mock but not in cells that contained ABidRz.
Next, we performed Western blotting for Bid in control and Bid-ribozyme transfected cells. The whole cell extract was separated on a 15 % SDS-PAGE gel, blotted to a membrane and probed with anti-Bid antibody.
The level of Bid protein was significantly reduced in ribozyme transfected clones as compared with that of vector transfected clones. Furthermore the clones isolated from transfections of IBidRz did not exhibit any difference as compared with a Mock clone. Apparently the inactive form of the ribozyme was neutral in cells.
These results demonstrated that Bid can be targeted by ribozymes and that these targeted derivatives should be useful for analysis of the mitichcondrial apoptosis pathway. Analysis of apoptotic response in control and Bidribozyme transfected MCF7 cells
We evaluated time-dependent activation of initiator caspases 8 and 9 or effector caspases 6 and 7 in the ABidRz clone or the IBidRz clone. Cell death of these clones was stimulated by 0.5 ng/p.1 TNFoc and lu.g/u.1 cycloheximide. After stimulation, cells were collected at 2, 4, 8, 16 and 24 hr and analyzed for expression of caspases by Western blotting using anti caspase 6, 7, 8 or 9 antibodies. No difference was observed for caspase 8 in any of the clones. Activation of caspases 7 and 9 was significantly delayed for Bid derivative clones. These results show that Bid mediated.apoptosis occurs from effector caspases 9 and 7. Therefore, caspase 9 is most likely an upstream activator of caspase 7 in TNFa induced Bid-mediated apoptosis in MCF7 cells. 
